Kerry Stokes’ Media Executives and Seven West Media’s Interest in Orthocell
Seven West Media shows a strong focus on ASX-listed medtech company Orthocell, a relatively obscure firm based in Perth. Orthocell specializes in cell regeneration therapies and originated from the University of Western Australia in 2007.
With a market capitalization fluctuating around $300 million, Orthocell has experienced an approximate 80% increase in value over the past year. Despite this growth, it remains one among many smaller medtech companies on the ASX.
“Most people wouldn’t have heard of Orthocell,”
Its steady rise and sector niche likely account for Seven West Media executives’ notable interest. Subscribing allows gifting five articles per month to others, encouraging broader dissemination of such specialized information.
Background and Market Performance
- Founded from the University of Western Australia in 2007
- Focuses on cell regeneration therapies
- Market cap around $300 million
- About 80% growth in the last year
Media Strategy and Outreach
Seven West Media uses subscriptions that allow gifting articles, fostering content sharing even about lesser-known companies like Orthocell.
Summary
Orthocell’s solid growth in a competitive medtech market attracts strategic media attention, reflecting its rising profile despite being relatively unknown.